Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02733393 · ClinicalTrials.gov registry record · Phase 1
Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy
A Phase 1 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT02733393 is a Phase 1 study that has completed, run by NYU Langone Health. The registered enrollment target is 2 participants.
The verdict
NCT02733393, a Phase 1 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) after thoracotomy. This will be an open label preliminary pilot study to determine if SPG block has potential utility to manage ISP in post-thoracotomy patients. The primary outcome variable will be reduction of shoulder pain.
Interventions
- DRUG lidocaine
- PROCEDURE Sphenopalatine Ganglion (SPG) Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-09-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02733393
The ClinicalTrials.gov registry entry for NCT02733393 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lidocaine is the first listed.
NCT02733393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02733393 about?
NCT02733393 is a clinical study titled "Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy". The purpose of this pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) after thoracotomy. This will be an open label preliminary pilot study to determine if SPG block has potential utility to manage ISP in post-thoracotomy patients...
What is the current status of trial NCT02733393?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2015-09. Estimated completion is 2017-09-05.
What interventions are being tested in trial NCT02733393?
The interventions under investigation include: lidocaine (DRUG), Sphenopalatine Ganglion (SPG) Block (PROCEDURE).
Who is sponsoring clinical trial NCT02733393?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.